| Literature DB >> 24374275 |
Hironori Inoue1, Daisuke Hidaka1, Seketsu Fukuzawa2, Kazuo Tachibana1.
Abstract
The marine alkaloid, norzoanthamine, is considered to be a promising drug for osteoporosis treatment. Due to its rarity and complicated structure, a practical supply method must be developed. Here, we designed a truncated norzoanthamine, which has two-thirds of the original structure, and found that it exhibited similar collagen protection activity.Entities:
Keywords: Alkaloid; Collagen; Norzoanthamine; Osteoporosis
Mesh：
Substances：
Year: 2013 PMID： 24374275 DOI： 10.1016/j.bmcl.2013.12.032
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN： 0960-894X Impact factor: 2.823